Implementation of an anonymisation tool for clinical trials using a clinical trial processor integrated with an existing trial patient data information system

被引:8
作者
Aryanto, Kadek Y. E. [1 ]
Broekema, Andre [1 ]
Oudkerk, Matthijs [1 ]
van Ooijen, Peter M. A. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9700 RB Groningen, Netherlands
关键词
Anonymisation tool; Clinical trial processor; Privacy; Clinical trials; Software; Patient data;
D O I
10.1007/s00330-011-2235-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To present an adapted Clinical Trial Processor (CTP) test set-up for receiving, anonymising and saving Digital Imaging and Communications in Medicine (DICOM) data using external input from the original database of an existing clinical study information system to guide the anonymisation process. Two methods are presented for an adapted CTP test set-up. In the first method, images are pushed from the Picture Archiving and Communication System (PACS) using the DICOM protocol through a local network. In the second method, images are transferred through the internet using the HTTPS protocol. In total 25,000 images from 50 patients were moved from the PACS, anonymised and stored within roughly 2 h using the first method. In the second method, an average of 10 images per minute were transferred and processed over a residential connection. In both methods, no duplicated images were stored when previous images were retransferred. The anonymised images are stored in appropriate directories. The CTP can transfer and process DICOM images correctly in a very easy set-up providing a fast, secure and stable environment. The adapted CTP allows easy integration into an environment in which patient data are already included in an existing information system. Store DICOM images correctly in a very easy set-up in a fast, secure and stable environment Allows adaptation of the software to perform a certain task based on specific needs Allows easy integration into an existing environment Reduce the possibility of inappropriate anonymisation.
引用
收藏
页码:144 / 151
页数:8
相关论文
共 50 条
  • [41] Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value
    Gillett, Piers
    Mahar, Robert K.
    Tran, Nancy R.
    Rosenthal, Mark
    Ijzerman, Maarten
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)
  • [42] Exploration of Using an Open-Source Large Language Model for Analyzing Trial Information: A Case Study of Clinical Trials With Decentralized Elements
    Huh, Ki Young
    Song, Ildae
    Kim, Yoonjin
    Park, Jiyeon
    Ryu, Hyunwook
    Koh, Jaeeun
    Yu, Kyung-Sang
    Kim, Kyung Hwan
    Lee, Seunghwan
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (03):
  • [43] Integrated safety profile of atacicept: an analysis of pooled data from the atacicept clinical trial programme
    Gordon, Caroline
    Bassi, Roberto
    Chang, Peter
    Kao, Amy
    Jayne, David
    Wofsy, David
    Fleuranceau-Morel, Patricia
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2019, 3 (02)
  • [44] Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials
    Susan Eggly
    Lauren M. Hamel
    Elisabeth Heath
    Mark A. Manning
    Terrance L. Albrecht
    Ellen Barton
    Mark Wojda
    Tanina Foster
    Michael Carducci
    Dina Lansey
    Ting Wang
    Rehab Abdallah
    Narineh Abrahamian
    Seongho Kim
    Nicole Senft
    Louis A. Penner
    BMC Cancer, 17
  • [45] Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value
    Piers Gillett
    Robert K Mahar
    Nancy R Tran
    Mark Rosenthal
    Maarten IJzerman
    Cost Effectiveness and Resource Allocation, 21
  • [46] Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials
    Eggly, Susan
    Hamel, Lauren M.
    Heath, Elisabeth
    Manning, Mark A.
    Albrecht, Terrance L.
    Barton, Ellen
    Wojda, Mark
    Foster, Tanina
    Carducci, Michael
    Lansey, Dina
    Wang, Ting
    Abdallah, Rehab
    Abrahamian, Narineh
    Kim, Seongho
    Senft, Nicole
    Penner, Louis A.
    BMC CANCER, 2017, 17
  • [47] Identifying patient information needs about cancer clinical trials using a Question Prompt List
    Brown, Richard F.
    Shuk, Elyse
    Butow, Phyllis
    Edgerson, Shawna
    Tattersall, Martin H. N.
    Ostroff, Jamie S.
    PATIENT EDUCATION AND COUNSELING, 2011, 84 (01) : 69 - 77
  • [48] Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation
    Tove Godskesen
    Peter Nygren
    Karin Nordin
    Mats Hansson
    Ulrik Kihlbom
    Supportive Care in Cancer, 2013, 21 : 3137 - 3142
  • [49] Autism and ADHD in the Era of Big Data; An Overview of Digital Resources for Patient, Genetic and Clinical Trials Information
    Abomelha, Faris M.
    AlDhalaan, Hesham
    Ghaziuddin, Mohammad
    Al-Tassan, Nada A.
    Al-Mubarak, Bashayer R.
    GENES, 2022, 13 (09)
  • [50] CTrO-Editor: A Web-based Tool to Capture Clinical Trial Data for Aggregation and Pooling
    Sanchez-Graillet, Olivia
    Kramer-Sunderbrink, Arne
    Cimiano, Philipp
    PROCEEDINGS OF THE 11TH KNOWLEDGE CAPTURE CONFERENCE (K-CAP '21), 2021, : 277 - 280